Green Cross Health Ltd · NZX:GXH
Green Cross Health — H1 2025 Earnings Presentation
19 slides from Green Cross Health's earnings presentation, Nov 28, 2024
Slide 1: Half Year Results Presentation
H alf Year R esults Presentation 28 November 2024
Slide 2: Disclaimer
Disclaimer The information in this presentation was prepared by Green Cross Health Limited (GXH) with due care and attention. However, the information is supplied in summary form and is therefore not necessarily complete, and no representation is made as to the accuracy, completeness or reliability
Slide 3: GXH Interim Result – Financial Overview
GXH Interim Result – Financial Overview $$$$ Group Operating Profit Net Profit After Tax Revenue (attributable to shareholders) (EBIT) $259.9m $16.1m $5.6m 4% increase vs 1H24 8% increase vs 1H24 1% increase vs 1H24 Pharmacy Medical Operating Profit Operating Profit $8.9m $8.2m 3% increase vs 1H24 1
Slide 4: Operational Highlights
Operational Highlights Group Pharmacy Medical Highlights Division Division • Operating Cashflow of $25.3m, up • Total prescriptions up 7% on same- • 423,000 enrolled patients (+24,000 38% due to improvements in working store basis year-on-year) capital management • Upgrade of Life Pharmacy ecommerce
Slide 5: Pharmacy Division
Pharmacy Division New Zealand’s largest network of health retailers: supporting easy access to quality health care
Slide 6: Pharmacy Performance
Pharmacy Performance Pharmacy Operating Revenue ($m) 179.7 181.5 182.2 • Revenue constant at $182.2m 169.9 • Operating Profit up 3% to $8.9m due to cost 1H22 1H 22 1H23 1H 23 1H24 1H 24 1H25 1H 25 and margin management initiatives Pharmacy Operating Profit ($m) • Same store labour costs flat despite
Slide 7: Operational Highlights - Pharmacy
Operational Highlights - Pharmacy Vaccination and Script Volumes Focus on Cost Control Initiatives 16 25% 350 20 14 20% 12 19 % of Revenue 300 10 EBIT ($m) 15% 8 18 6 10% 250 4 5% Total Vaccinations (000's) 17 2 Total Scripts (m) 185 0 0% 200 175 183 1H22 1H23 1H24 1H25 16 EBIT Employee costs % Othe
Slide 8: Different Ways of Reaching the Customer
Different Ways of Reaching the Customer 86 million 44 million 6.3 million 52,000 views emails sent page views 9,000 Uber service across to Living on Life Eats orders bookings social media Rewards website since launch made online channels members Adapting to customer shopping habits with an upgrade o
Slide 9: Pharmacy Strategy and Future Focus
Pharmacy Strategy and Future Focus Brand & Retail Omni-channel Network scale & Cost focus customer disciplines experience leadership Differentiated brands Professional instore Care & advice Leveraging our trusted Workforce and products & experience & margin accessible to the brands & advocating for
Slide 10: Medical Division
Medical Medical Division Division Growth, leadership and sustainable models of care Growth, leadership and sustainable models of care
Slide 11: Medical Performance
Medical Performance Medical Operating Revenue ($m) 68.2 68.6 77.7 46.1 Revenue up 13% to $77.7m driven by 1H22 1H22 1H23 1H23 1H24 1H24 1H25 1H25 organic and acquisitive growth Operating Profit up 12% to $8.2m, in Medical Operating Profit ($m) line with revenue growth 423,000 enrolled patients as at
Slide 12: Operational Highlights - Medical
Operational Highlights - Medical Increased Efficiencies Through Operational Improvements and Systematic Triaging Focus on cost and margin 10 80% management through procurement 9 activity to ensure opportunities from the 70% 8 group’s scale are maximised 60% 7 Investment in technology to enhance 50%
Slide 13: Evolving the Operating Model
Evolving the Operating Model Enhanced Nurse Care 423,000 enrolled patients Practitioners Paramedics Over 110,000 active users on The Doctors App allowing patients convenient management of appointments, repeat prescription requests and The Doctors Nurse-led management of ongoing health conditions App
Slide 14: Medical Strategy and Future Focus
Medical Strategy and Future Focus Patient & Brand Scale Technology Operations Cost & Margin Improvement High quality patient Targeted centre Utilising data and Continuous Workforce care acquisitions systems & omni- improvement & clinical productivity & channel offering development margin management
Slide 15: Group Financial Results
Group Financial Results 6 months ending 30 September 2024
Slide 16: Group Revenue and Operating Profit
Group Revenue and Operating Profit GXH GXHOperating OperatingRevenue RevenueFrom FromContinuing ContinuingOperations ($m) GXH Operating Profit From Continuing Operations ($m) Operations ($m) 247.9 250.2 259.9 17.8 18.1 216.0 14.9 16.1 1H22 1H23 1H24 1H25 1H22 1H23 1H24 1H25 • Revenue $259.9m, up 4%
Slide 17: Group NPAT, EPS & Dividend
Group NPAT, EPS & Dividend GXH NPAT Attributable to Shareholders From Dividends Per Share (cps) Continuing Operations ($m) 31.5 7.8 7.1 5.6 5.6 3.5 0.0 2.0 1H22 1H23 1H24 1H25 1H22 1H22 1H23 1H23 1H24 1H24 1H25 1H25 Based on dividends paid during the financial year 1H24 includes special dividend of
Slide 18: Working Capital and Operating Cashflow
Working Capital and Operating Cashflow Gearing Ratio (debt / debt + equity) GXH Operating Cash Flow ($m) 16.2% 16.9% 28.9 14.3% 12.4% 25.3 17.8 18.3 1H22 1H23 1H24 1H25 1H22 FY21 1H23 FY22 1H24 FY23 1H25 FY24 • Gearing ratio of 16.9% as at 30 September 2024 • Operating Cash Flow of $25.3m • Undrawn
Slide 19: Our Purpose
Our Purpose: Working together to support healthier communities. We are passionately committed to the health and wellness of New Zealand, and to providing the best support, care and advice to our communities. This is our promise. GXH Half Year Results Presentation 28 November 2024 19